PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

Rhea-AI Summary

PAVmed (NASDAQ: LUCD) will hold a Fourth Quarter and Full Year 2025 business update conference call and webcast on March 30, 2026 at 8:30 AM ET. Management will review operations, growth strategy and fourth quarter 2025 financial results.

The webcast will be available in the investor relations section at pavmed.com and a telephone dial-in is provided for U.S. and international callers. A replay will be accessible on the company website for 30 days.

News Market Reaction – LUCD

+2.19%

+2.19% Session close to close

In the Mar 16 session, LUCD gained 2.19%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Conference Call and Webcast at 8:30 AM ET

NEW YORK, March 16, 2026 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Monday, March 30, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, PAVmed's President and Chief Financial Officer, will discuss the Company's fourth quarter 2025 financial results.

The webcast will be available at the investor relations section of the Company's website at pavmed.com. Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "PAVmed Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.

About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard^® Esophageal DNA Test and EsoCheck^® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.

For more information about PAVmed, please visit pavmed.com.

For more information about Lucid Diagnostics, please visit luciddx.com.

For more information about Veris Health, please visit verishealth.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-fourth-quarter-and-full-year-2025-business-update-conference-call-and-webcast-on-march-30-2026-302710623.html

SOURCE PAVmed Inc.

FAQ

When is PAVmed's (LUCD) Q4 and full year 2025 business update conference call?

The call is scheduled for March 30, 2026 at 8:30 AM ET. According to the company, management will present a business update and discuss fourth quarter 2025 financial results during that call.

How can I listen to PAVmed (LUCD) conference call and webcast on March 30, 2026?

Listen via the live webcast on the company's investor relations website or by phone. According to the company, U.S. callers should dial 1-800-836-8184; international callers 1-646-357-8785.

Who will present on PAVmed's (LUCD) March 30, 2026 business update call?

PAVmed's chairman and CEO, Lishan Aklog, M.D., and President/CFO Dennis McGrath will present. According to the company, they will discuss operations, growth strategy and Q4 2025 financial results.

Will a replay of PAVmed's (LUCD) March 30, 2026 call be available and for how long?

Yes. A replay will be available for 30 days on the company's investor relations website. According to the company, the replay will be posted following the conclusion of the conference call.

What topics will PAVmed (LUCD) cover during the March 30, 2026 business update?

The call will cover the company's operations, growth strategy and fourth quarter 2025 financial results. According to the company, management will provide a business update and discuss financial performance.